Man Group’s Exagen XGN Stock Holding History

Man Group’s Portfolio XGN Stock Details XGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$389K	Buy	129,710 +97,104	+298%	+$376K	﹤0.01%	2146
2025 Q4	$198K	Buy	+32,606	New	+$297K	﹤0.01%	2126

Other funds holding XGN

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Wexford Capital West Palm Beach, Florida $690M AUM 57.92% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

NCNMGF

Nano-Cap New Millennium Growth Fund Staten Island, New York $107M AUM

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

KCM

Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return

FCM

FourWorld Capital Management New York $196M AUM 42.39% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

MBAM

Mink Brook Asset Management West Palm Beach, Florida $179M AUM 37.68% 1-Year Est. Return

Man Group's XGN Position: Q1 2026 in Review

Man Group increased its Exagen (XGN) stake by 298% in Q1 2026, buying an estimated $376K and bringing the position to 129,710 shares worth $389K. The position accounts for ﹤0.01% of the portfolio, ranked #2146.

Man Group first reported a position in XGN in Q4 2025 and has held it in 2 quarters since. 61 funds tracked by Wall St. Rank hold XGN as of Q1 2026.

Man Group held 129,710 shares of Exagen worth $389K as of Q1 2026.
Man Group bought 97,104 Exagen shares in Q1 2026, an estimated $376K.
Exagen made up ﹤0.01% of Man Group's portfolio in Q1 2026, its #2146 holding.
Man Group first reported a position in Exagen in Q4 2025 and has held it in 2 quarters since.
61 funds tracked by Wall St. Rank held Exagen as of Q1 2026.

Based on Man Group's 13F filing for Q1 2026, filed 15 May 2026.